NeuroQuant
Overview
NeuroQuant by CorTechs Labs (also known as Cortechs.ai) is a fully automated advanced imaging software designed for comprehensive brain MRI segmentation and volumetric quantification. This AI-powered medical device aids physicians in the detection, diagnosis, and monitoring of a wide range of neurological conditions by providing objective, quantitative data on brain structure volumes and lesion analysis.
The software integrates seamlessly into radiology workflows, offering fast and accurate analysis of 3D T1 MRI scans, and optionally T2 FLAIR and T2* GRE/SWI series for lesion quantification. NeuroQuant compares individual patient brain structure volumes to a unique normative database, which includes data from healthy individuals aged 3 to 100, normalized for age, gender, and intracranial volume.
Key functionalities include longitudinal tracking to assess changes in brain structure volumes and lesions over time, customizable volumetric reports, and advanced capabilities for segmenting and quantifying Amyloid-Related Imaging Abnormalities (ARIA) in Alzheimer’s patients, as well as various brain tumors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Fully automated brain segmentation and volumetric analysis
- Quantitative 3D T1 MRI post-processing image analysis
- Comparison to normative database (ages 3-100, age/gender matched)
- Longitudinal tracking of brain structure volumes and lesion changes over time
- Detection and quantification of ARIA-E and ARIA-H
- Segmentation and quantification of brain lesions (T2 FLAIR hyperintense, T2* GRE/SWI hypointense)
- Customizable volumetric reports
- Seamless integration into PACS systems
- Cloud-based AI software
- Supports data from all major MRI manufacturers
Use Cases
- Assessment of neurodegenerative diseases (e.g., Alzheimer's, other dementias)
- Monitoring Multiple Sclerosis (MS) progression and treatment
- Evaluation of Traumatic Brain Injury (TBI)
- Diagnosis and assessment of epilepsy
- Quantification of brain tumors (gliomas, metastases, meningiomas)
- Assessment of brain development abnormalities
What Physicians Need to Know
Utilize NeuroQuant for objective, quantitative data to complement visual MRI interpretation, especially for detecting subtle brain changes that might be missed otherwise. Leverage its longitudinal tracking capabilities to monitor disease progression and assess treatment efficacy in conditions like Alzheimer's, MS, and TBI. Employ the Hippocampal Asymmetry Report for precise evaluation in epilepsy, aiding in diagnosis and surgical planning. Consider NeuroQuant CT for automated analysis and conspicuity enhancement in stroke detection on CT scans. Use custom reports to tailor volumetric analysis to specific clinical questions or less common neurological conditions. Always interpret NeuroQuant results in conjunction with other clinical information for a comprehensive patient assessment.
NeuroQuant is designed for seamless integration into existing radiology workflows. It supports DICOM SR (Structured Reporting) output, facilitating interoperability with PACS, structured reporting systems (e.g., PowerScribe, Syngo.via), and EHR workflows, which helps reduce manual data entry and transcription errors. Strategic partnerships, such as with Siemens Healthineers, further enhance its integration into imaging ecosystems. The cloud-based platform ensures scalable deployment across healthcare networks, and its Brain Tumor module also integrates into radiation oncology and neurosurgical workflows.
Details
| Category | Neurology AI |
| Pricing | Subscription — Based on number of analyses; Based on number of installations |
| Deployment | Cloud-based; Computing appliance (local) |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated NeuroQuant has received multiple FDA 510(k) clearances, with the latest NeuroQuant 5.0 cleared for advanced segmentation and quantification of MRI lesions, including Amyloid-Related Imaging Abnormalities (ARIA) in Alzheimer's patients, Traumatic Brain Injury (TBI), and Cerebral Amyloid Angiopathy (CAA). It is intended for automatic labeling, visualization, and volumetric quantification of segmentable brain structures and lesions from MR images. |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Oncology, Radiology |
What the Web Says
NeuroQuant is an FDA-cleared software that analyzes standard brain MRI images to provide precise volumetric measurements of brain structures. It helps physicians detect subtle changes in brain volume that may be associated with conditions like Alzheimer's disease, multiple sclerosis, and traumatic brain injury, often identifying atrophy more sensitively than visual inspection by radiologists. The software compares individual brain volumes to a normative database adjusted for age, sex, and cranial volume, offering objective data for diagnosis, treatment planning, and monitoring neurological conditions over time.
Overall: PositiveStrengths
- More sensitive in detecting subtle brain atrophy and volume loss compared to traditional visual MRI interpretation.
- Provides objective, quantitative data for brain structure volumes, reducing subjectivity in diagnosis.
- Aids in earlier detection and monitoring of various neurological conditions, including Alzheimer's, MS, and TBI.
- Integrates into existing radiology workflows and generates reports quickly.
- Helps clinicians communicate findings more clearly with patients.
- Validated against gold-standard research methods and supported by numerous peer-reviewed studies.
Limitations
- Some neurologists not familiar with mold-related illnesses may be dismissive of NeuroQuant findings in that context.
- Insurance coverage can vary, and some plans may require additional documentation or justification.
- Requires specific MRI acquisition protocols for optimal accuracy, and artifacts can degrade results.
- While good for quantifying volume loss, it is less effective at identifying non-volume-related abnormalities.
- A low percentile finding is a flag, not a diagnosis, and needs to be interpreted alongside other clinical information.
- Some users on Reddit have expressed frustration with doctors not taking NeuroQuant reports seriously or radiologists not fully interpreting the detailed findings.
Based on reviews from: Reddit, HealthAidb, YouTube, PMC, Radiology Today Magazine, South Jersey Radiology, Intermountain Medical Imaging, Cortechs.ai, InventUM
Last updated: 2026-07-18
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate NeuroQuant
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for NeuroQuant.
Transforming Brain Imaging with NeuroQuantu00ae CT & NeuroQuantu00ae Brain Tumor | Dr. Niky Farid
Cortechs
NeuroQuant MS: The Future of Multiple Sclerosis Detection and Management
Cortechs
Standardizing Brain Imaging for Better Care Using NeuroQuant Brain Tumor
Cortechs
What the Experts Say About NeuroQuant & NeuroQuant MS
Cortechs
Philips IntelliSpace Portal 9.0 clinical application MR NeuroQuantu00ae
Philips Healthcare
Updates to NeuroQuant MS
Cortechs
Frequently Asked Questions
Compare NeuroQuant
VS
VS
